In this regard, although the anti-inflammatory effect of ITF3756 on the TNF-α signaling pathway could be seen as a disadvantage for certain aspects of cancer therapy, in the context of immune checkpoint therapy combinations it could be helpful and relevant. The gene discussed is TNF; the disease is cancer.